-
1
-
-
77957979474
-
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
-
Chamberlain MC.Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.Expert Rev Neurother. 2010;10:1537-1544.
-
(2010)
Expert Rev Neurother
, vol.10
, pp. 1537-1544
-
-
Chamberlain, M.C.1
-
2
-
-
79959370997
-
Temozolomide: the evidence for its therapeutic efficacy in malignant astrocytomas
-
Omar AI,Mason WP.Temozolomide: the evidence for its therapeutic efficacy in malignant astrocytomas.Core Evid. 2010;4:93-111.
-
(2010)
Core Evid
, vol.4
, pp. 93-111
-
-
Omar, A.I.1
Mason, W.P.2
-
3
-
-
73849110612
-
Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells
-
Chen M,Rose AE,Doudican N, et al.Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells.Mol Cancer Res. 2009;7:1946-1953.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1946-1953
-
-
Chen, M.1
Rose, A.E.2
Doudican, N.3
-
4
-
-
84875145824
-
Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells
-
Filippi-Chiela EC,Thomé MP,Bueno e Silva MM, et al.Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.BMC Cancer. 2013;13:147-147.
-
(2013)
BMC Cancer
, vol.13
, pp. 147
-
-
Filippi-Chiela, E.C.1
Thomé, M.P.2
Bueno e Silva, M.M.3
-
5
-
-
0034528247
-
New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance
-
Spiro T,Liu L,Gerson S.New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.Forum (Genova). 2000;10:274-285.
-
(2000)
Forum (Genova)
, vol.10
, pp. 274-285
-
-
Spiro, T.1
Liu, L.2
Gerson, S.3
-
6
-
-
84880907077
-
Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers
-
Mullins CS,Schubert J,Schneider B, et al.Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers.J Cancer Res Clin Oncol. 2013;139:1425-1431.
-
(2013)
J Cancer Res Clin Oncol
, vol.139
, pp. 1425-1431
-
-
Mullins, C.S.1
Schubert, J.2
Schneider, B.3
-
7
-
-
0038743077
-
Induction of autophagic cell death in malignant glioma cells by arsenic trioxide
-
Kanzawa T,Kondo Y,Ito H, et al.Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.Cancer Res. 2003;63:2103-2108.
-
(2003)
Cancer Res
, vol.63
, pp. 2103-2108
-
-
Kanzawa, T.1
Kondo, Y.2
Ito, H.3
-
8
-
-
80052634162
-
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
-
Henriksson R,Asklund T,Poulsen HS.Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review.J Neurooncol. 2011;104:639-646.
-
(2011)
J Neurooncol
, vol.104
, pp. 639-646
-
-
Henriksson, R.1
Asklund, T.2
Poulsen, H.S.3
-
9
-
-
84861314378
-
A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised phase III clinical trial: has a more radical approach improved survival?
-
Rock K,McArdle O,Forde P, et al.A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised phase III clinical trial: has a more radical approach improved survival?.Br J Radiol. 2012;85:e729-e733.
-
(2012)
Br J Radiol
, vol.85
-
-
Rock, K.1
McArdle, O.2
Forde, P.3
-
10
-
-
82355184374
-
Towards personalized therapy for patients with glioblastoma
-
Shirai K,Chakravarti A.Towards personalized therapy for patients with glioblastoma.Expert Rev Anticancer Ther. 2011;11:1935-1944.
-
(2011)
Expert Rev Anticancer Ther
, vol.11
, pp. 1935-1944
-
-
Shirai, K.1
Chakravarti, A.2
-
11
-
-
38949170191
-
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide
-
Kil WJ,Cerna D,Burgan WE, et al.In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.Clin Cancer Res. 2008;14:931-938.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 931-938
-
-
Kil, W.J.1
Cerna, D.2
Burgan, W.E.3
-
12
-
-
68249151989
-
Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro
-
Gao S,Yang XJ,Zhang WG, et al.Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.Chin Med J (Engl). 2009;122:1260-1266.
-
(2009)
Chin Med J (Engl)
, vol.122
, pp. 1260-1266
-
-
Gao, S.1
Yang, X.J.2
Zhang, W.G.3
-
13
-
-
80052752206
-
Effect of temozolomide on the U-118 glioma cell line
-
Carmo A,Carvalheiro H,Crespo I, et al.Effect of temozolomide on the U-118 glioma cell line.Oncol Lett. 2011;2:1165-1170.
-
(2011)
Oncol Lett
, vol.2
, pp. 1165-1170
-
-
Carmo, A.1
Carvalheiro, H.2
Crespo, I.3
-
14
-
-
79955782730
-
Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation
-
Chen CH,Chang YJ,Ku MS, et al.Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation.J Mol Med (Berl). 2011;89:303-315.
-
(2011)
J Mol Med (Berl)
, vol.89
, pp. 303-315
-
-
Chen, C.H.1
Chang, Y.J.2
Ku, M.S.3
-
15
-
-
33645105856
-
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
-
Hermisson M,Klumpp A,Wick W, et al.O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.J Neurochem. 2006;96:766-776.
-
(2006)
J Neurochem
, vol.96
, pp. 766-776
-
-
Hermisson, M.1
Klumpp, A.2
Wick, W.3
-
16
-
-
84867385981
-
Autophagy, polyphenols and healthy ageing
-
Pallauf K,Rimbach G.Autophagy, polyphenols and healthy ageing.Ageing Res Rev. 2013;12:237-252.
-
(2013)
Ageing Res Rev
, vol.12
, pp. 237-252
-
-
Pallauf, K.1
Rimbach, G.2
-
18
-
-
84861062884
-
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments
-
Palumbo S,Pirtoli L,Tini P, et al.Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments.J Cell Biochem. 2012;113:2308-2318.
-
(2012)
J Cell Biochem
, vol.113
, pp. 2308-2318
-
-
Palumbo, S.1
Pirtoli, L.2
Tini, P.3
-
21
-
-
13444252965
-
Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins
-
Ellington AA,Berhow M,Singletary KW.Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins.Carcinogenesis. 2005;26:159-167.
-
(2005)
Carcinogenesis
, vol.26
, pp. 159-167
-
-
Ellington, A.A.1
Berhow, M.2
Singletary, K.W.3
-
22
-
-
19644373959
-
Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence
-
Hirose Y,Katayama M,Mirzoeva OK, et al.Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence.Cancer Res. 2005;65:4861-4869.
-
(2005)
Cancer Res
, vol.65
, pp. 4861-4869
-
-
Hirose, Y.1
Katayama, M.2
Mirzoeva, O.K.3
-
23
-
-
1842865745
-
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
-
Kanzawa T,Germano IM,Komata T, et al.Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.Cell Death Differ. 2004;11:448-457.
-
(2004)
Cell Death Differ
, vol.11
, pp. 448-457
-
-
Kanzawa, T.1
Germano, I.M.2
Komata, T.3
-
24
-
-
35648934994
-
Temozolomide induces senescence but not apoptosis in human melanoma cells
-
Mhaidat NM,Zhang XD,Allen J, et al.Temozolomide induces senescence but not apoptosis in human melanoma cells.Br J Cancer. 2007;97:1225-1233.
-
(2007)
Br J Cancer
, vol.97
, pp. 1225-1233
-
-
Mhaidat, N.M.1
Zhang, X.D.2
Allen, J.3
|